Biogen Q3 results better than expected, updrades guidance
![Photo: Brian Snyder/Reuters/Ritzau Scanpix](https://photos.watchmedier.dk/watchmedier/resize:fill:3840:0:0/plain/https://photos.watchmedier.dk/Images/article13386936.ece/ALTERNATES/schema-16_9/20211020-132344-4-1920x1078we.jpg)
The US premarket indicator for Biogen stock is up 1.8 percent at USD 273.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Biogen stumbles in crucial ALS study
For subscribers
Roche soars in Q3, carried by Covid-19 test demand
For subscribers